Please contact me directly to request a pdf of any article (ejs@wsu.edu). 

• Hewage IM, Church KEM, Schwartz EJ. (2024) Investigating the impact of vaccine hesitancy on an emerging infectious disease: a mathematical and numerical analysis. Journal of Biological Dynamics, 18:1. [link]
• Tchoumi SY, Schwartz EJ, Tchuenche JM. (2024) A deterministic model of COVID-19 with differential infectivity and vaccination booster. Decision Analytics Journal, 10:100374. [link]
• Bailes CL, Biggs KRH, Scott L, Wichman HA, Schwartz EJ. (2023) Genetic and functional basis of the reduction effect in bacteriophage ΦX174. Virology 588:109905. [link]
• Hull-Nye D, Meadows T, Smith? SR, Schwartz EJ. (2023) Key factors and parameter ranges for immune control of equine infectious anemia virus infection. Viruses 15:691. [link]
• Meadows T, Schwartz EJ. (2023) A model of virus infection with immune responses supports boosting CTL response to balance antibody response. In Computational and Mathematical Population Dynamics; Tuncer N, Martcheva M, Prosper O, Childs L, Eds.; World Scientific Publishing Europe Ltd.: London UK, 4:145-168. [arxiv link]
• Schwartz EJ, Costris-Vas C, Smith? SR. (2021) Modelling mutation in equine infectious anemia virus infection suggests a path to viral clearance with repeated vaccination. Viruses 13(12):2450. [link]
• Johnson SS, Jackson KC, Mietchen MS, Sbai S, Schwartz EJ, Lofgren ET. (2021) Excess risk of COVID-19 to university populations resulting from in-person sporting events. International Journal of Environmental Research and Public Health 18(16):8260. [link]
• Biggs KRH, Bailes CL, Scott L, Wichman HA, Schwartz EJ. (2021) Ecological approach to understanding superinfection inhibition in bacteriophage. Viruses 13(7):1389. [link]
• Gudaz H, Ogu HA, Schwartz EJ. (2020) Long-term dynamics of the kidney disease epidemic among HIV-infected individuals. Spora 6(1):52-60. [link]
• Costris-Vas C, Schwartz EJ, Smith? R. (2020) Predicting COVID-19 using past pandemics as a guide: how reliable were mathematical models then, and how reliable will they be now? Mathematical Biosciences and Engineering 17(6):7502-7518. [link]
• Hull-Nye D, Malik B, Keshavamurthy R, Schwartz EJ. (2020) Transient dynamics of the kidney disease epidemic among HIV-infected individuals. Mathematics in Applied Sciences and Engineering 1(4):371-380. [link]
• Cangelosi RA, Schwartz EJ, Wollkind DJ. (2018) A quasi-steady-state approximation to the basic viral dynamics model with a non-cytopathic effect. Frontiers in Microbiology 9:54. [link]
• Schwartz EJ, Vaidya NK, Dorman K, Carpenter S, Mealey RH. (2018) Dynamics of lentiviral infection in vivo in the absence of adaptive host immune responses. Virology 513:108-113. [link]
• Pawelek KA, Tobin S, Griffin C, Ochocinski D, Schwartz EJ, Del Valle S. (2017) Impact of an imperfect vaccine and altered behavior on the spread of influenza. AIMS Medical Science 4(2):217-232. [link]
• Schwartz EJ, Biggs KRH, Bailes C, Ferolito KA, Vaidya NK. (2016) HIV dynamics with immune responses: Perspectives from mathematical modeling. Current Clinical Microbiology Reports 3:216-224. [link]
• Schwartz EJ, Choi B, Rempala GA. (2015) Estimating epidemic parameters: Application to H1N1 pandemic data. Mathematical Biosciences 270(Pt B):198-203. [link]
• Allen LJS, Schwartz EJ. (2015) Free-virus and cell-to-cell transmission in models of equine infectious anemia virus. Mathematical Biosciences 270(Pt B):237-48. [link]
• Schwartz EJ, Nanda S, Mealey RH. (2015) Antibody escape kinetics of EIAV infection of horses. Journal of Virology 89(13):6945-51. [link]
• Schwartz EJ, Morgan M, Lapin S. (2015) Pandemic 2009 H1N1 influenza in two settings in a small community: the workplace and the university campus. Epidemiology & Infection 143:1606-9. [link]
• Vaidya NK, Morgan M, Jones T, Miller L, Lapin S, Schwartz EJ. (2015) Modelling the epidemic spread of an H1N1 influenza outbreak in a rural university town. Epidemiology & Infection 143:1610-20. [link]
• Schwartz EJ, Smith? RJ. (2014) Identifying the conditions under which antibodies protect against infection by equine Infectious anemia virus. Vaccines 2:397-421. [link]
• Ciupe SM, Schwartz EJ. (2014) Understanding virus-host dynamics following EIAV infection in SCID horses. J. Theoretical Biology 343:1-8. [link]
• Schwartz EJ, Yang OO, Cumberland WG, de Pillis LG. (2013) Computational model of HIV-1 escape from the cytotoxic T lymphocyte response. Canadian Applied Mathematics Quarterly 21(2):261-279. [link]
• Miller L, Jones T, Morgan M, Lapin S, Schwartz EJ. (2013) Individual-based computational model used to explain 2009 pandemic H1N1 in rural campus community. J. Biological Systems 21(4):134005. [link]
• Schwartz EJ, Pawelek KA, Harrington K, Cangelosi R, Madrid S. (2013) Immune control of equine infectious anemia virus infection by cell-mediated and humoral responses. Applied Mathematics 4:171-177. [link]
• Mushayabasa S, Bhunu CP, Schwartz EJ, Magombedze G, Tchuenche JM. (2011) Socio-economic status and HIV/AIDS dynamics: a modeling approach. World Journal of Modeling and Simulation 7(4):243-57. [link]
• Snedecor SJ, Strutton D, Ciuryla V, Schwartz EJ, Botteman M. (2009) Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations. Vaccine 27(34):4694-703. [link]
• Anton PA, Ibarrondo FJ, BoscardinWJ, Zhou Y, Schwartz EJ, Ng HL, Hausner MA, Shih R, Elliott J, Hultin PM, Hultin LE, Price C, Fuerst M, Adler A, Wong JT, Yang OO, and Jamieson BD. (2008) Differential Immunogenicity of Vaccinia and HIV-1 Components of a Recombinant Vaccine in Mucosal and Blood Compartments. Vaccine 26:4617-4623. [link]
• Smith RJ, Schwartz EJ. (2008) Predicting the potential impact of a cytotoxic T lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be? Mathematical Biosciences 212:180-187. [link]
• Schwartz EJ, Bodine EN, Blower S. (2007) Effectiveness and Efficiency of Imperfect Therapeutic HSV-2 Vaccines. Human Vaccines 3(6):231-238. [link]
• Breban R, McGowan I, Topaz C, Schwartz EJ, Anton P, Blower S. (2006) Modeling the Potential Impact of Rectal Microbicides to Reduce HIV Transmission in Bathhouses. Mathematical Biosciences and Engineering 3(3):459-66. [link]
• Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. (2005) Highly Active Antiretroviral Therapy and the Epidemic of HIV+ End-Stage Renal Disease. Journal of American Society of Nephrology 16(8):2412-20. [link]
• Schwartz EJ, Blower S. (2005) Predicting the Potential Individual- and Population-Level Effects of Imperfect Herpes Simplex Virus Type 2 Vaccines. Journal of Infectious Diseases 191(10):1734-46. [link]
• Blower SM, Schwartz EJ, Mills J. (2003) Forecasting the future of HIV epidemics: the impact of antiretroviral therapies and imperfect vaccines. AIDS Reviews 5(2):113-125. [link]
• Sunamoto M, Husain M, He JC, Schwartz EJ, Klotman PE. (2003) Critical Role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney International 64(5):1695-1701. [link]
• Schwartz EJ, Fierer DS, Neumann AU, Keller MJ, Parkas V, Klotman ME, Winston JA, Klotman PE. (2002) HIV-1 Dynamics in Hemodialysis Patients. AIDS 16(9):1301-1303. [link]
• Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, Klotman PE. (2002) HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. Journal of the American Society of Nephrology 13(7):1806-15. [link]
• Schwartz EJ, Neumann AU, Teixeira AV, Bruggeman LA, Rappaport J, Perelson AS, Klotman PE. (2002) Effect of Target Cell Availability on HIV-1 Production in Vitro. AIDS 16(3):341-345. [link]
• Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, Mundel P, Klotman PE. (2001) HIV-1 Induces Loss of Contact Inhibition in Podocytes. Journal of the American Society of Nephrology 12(8):1677-84. [link]
• Schwartz EJ, Klotman PE. (1998) Pathogenesis of Human Immunodeficiency Virus-Associated Nephropathy. Seminars in Nephrology 18(4):436-445. [link]
• Rappaport J, Cho Y-Y, Hendel H, Schwartz EJ, Schachter F, Zagury J-F. (1997) 32 BP CCR-5 Gene Deletion and Resistance to Fast Progression in HIV-1 Infected Heterozygotes. The Lancet 349:922. [link]
• Morgello S, Uson RR, Schwartz EJ, Haber RS. (1995) The Human Blood-Brain Barrier Glucose Transporter (GLUT1) is a Glucose Transporter of Gray Matter Astrocytes. Glia 14:43-54. [link]